Avallone A, Giuliani F, De Stefano A, Santabarbara G, et al. Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial. J Clin Oncol 2024 Nov 22:JCO2400979. doi: 10.1200/JCO.24.00979.
PMID: 39576946